CIK 0001104506 · Large accelerated filer
INSMED Inc
Sign in to watch- Ticker
- INSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- operating
- EIN
- 541972729
- Phone
- 908-977-9900
- Business address
- 700 US HIGHWAY 202/206, BRIDGEWATER, NJ, 08807
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,737,650
- in 2 filings
Net −$3,737,650. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-19 | Lewis William Chair and CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −6,259 | 50,073 | ||
| 2026-03-19 | Lewis William Chair and CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −4,440 | 35,520 | ||
| 2026-03-05 | Lewis William Chair and CEO | Option exercise 10b5-1 | +6,259 | $30.46 | $191K | 307,444 |
| 2026-03-05 | Lewis William Chair and CEO | Option exercise 10b5-1 | +4,440 | $17.16 | $76K | 311,884 |
| 2026-03-05 | Lewis William Chair and CEO | Sale 10b5-1 | −2,083 | $144.23 | $300K | 309,801 |
| 2026-03-05 | Lewis William Chair and CEO | Sale 10b5-1 | −2,589 | $145.27 | $376K | 307,212 |
| 2026-03-05 | Lewis William Chair and CEO | Sale 10b5-1 | −3,899 | $146.66 | $572K | 303,313 |
| 2026-03-05 | Lewis William Chair and CEO | Sale 10b5-1 | −2,128 | $147.54 | $314K | 301,185 |
| 2026-03-05 | Lewis William Chair and CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −6,259 | 56,332 | ||
| 2026-03-05 | Lewis William Chair and CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −4,440 | 39,960 | ||
| 2026-03-03 | SHAROKY MELVIN MD Director | Gift | −100 | 242,776 | ||
| 2026-02-25 | SHAROKY MELVIN MD Director | Gift | −1,072 | 242,876 | ||
| 2026-02-25 | SHAROKY MELVIN MD Director | Gift | +243 | 5,423 | ||
| 2026-02-25 | SHAROKY MELVIN MD Director | Gift | +243 | 3,724 | ||
| 2026-02-25 | SHAROKY MELVIN MD Director | Gift | +243 | 5,007 | ||
| 2026-02-25 | SHAROKY MELVIN MD Director | Gift | +243 | 819 | ||
| 2026-02-24 | Smith Michael Alexander Chief Legal Officer | Option exercise 10b5-1 | +20,248 | $17.07 | $346K | 76,645 |
| 2026-02-24 | Smith Michael Alexander Chief Legal Officer | Sale 10b5-1 | −4,852 | $153.93 | $747K | 71,793 |
| 2026-02-24 | Smith Michael Alexander Chief Legal Officer | Sale 10b5-1 | −4,151 | $155.06 | $644K | 67,642 |
| 2026-02-24 | Smith Michael Alexander Chief Legal Officer | Sale 10b5-1 | −15,771 | $156.53 | $2.5M | 51,871 |
Page 7 of 23 · 448 trades